Nu Skin Enterprises (NYSE:NUS)‘s stock had its “underperform” rating restated by equities research analysts at Bank of America in a research note issued to investors on Thursday, MarketBeat Ratings reports. They presently have a $65.00 price objective on the stock, down from their previous price objective of $75.00. Bank of America’s price objective would indicate a potential upside of 1.91% from the company’s current price.
A number of other research firms have also recently weighed in on NUS. DA Davidson started coverage on shares of Nu Skin Enterprises in a research note on Tuesday, October 9th. They set a “buy” rating and a $92.00 target price on the stock. Jefferies Financial Group restated a “buy” rating and set a $92.00 target price on shares of Nu Skin Enterprises in a research note on Thursday, November 8th. Zacks Investment Research cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 8th. Citigroup set a $88.00 price target on shares of Nu Skin Enterprises and gave the stock a “buy” rating in a research note on Thursday, November 8th. Finally, Tigress Financial reiterated a “buy” rating on shares of Nu Skin Enterprises in a research note on Wednesday, November 21st. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $83.63.
Shares of Nu Skin Enterprises stock opened at $63.78 on Thursday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.25 and a current ratio of 1.93. Nu Skin Enterprises has a 1-year low of $60.60 and a 1-year high of $88.68. The firm has a market cap of $3.54 billion, a PE ratio of 19.75, a price-to-earnings-growth ratio of 1.62 and a beta of 0.99.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, November 7th. The company reported $0.94 earnings per share for the quarter, missing analysts’ consensus estimates of $0.96 by ($0.02). Nu Skin Enterprises had a net margin of 5.93% and a return on equity of 27.50%. The firm had revenue of $675.31 million for the quarter, compared to analysts’ expectations of $664.99 million. During the same quarter last year, the firm posted $0.76 EPS. The firm’s quarterly revenue was up 19.8% compared to the same quarter last year. As a group, equities analysts expect that Nu Skin Enterprises will post 3.51 EPS for the current fiscal year.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 2,500 shares of the business’s stock in a transaction on Monday, November 12th. The shares were sold at an average price of $65.34, for a total value of $163,350.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last quarter, insiders sold 7,500 shares of company stock worth $537,625. Corporate insiders own 5.20% of the company’s stock.
A number of hedge funds have recently made changes to their positions in NUS. Harvest Fund Management Co. Ltd increased its holdings in shares of Nu Skin Enterprises by 162.9% in the 3rd quarter. Harvest Fund Management Co. Ltd now owns 1,291 shares of the company’s stock worth $106,000 after buying an additional 800 shares during the last quarter. Global X Management Co LLC increased its holdings in shares of Nu Skin Enterprises by 141.9% in the 2nd quarter. Global X Management Co LLC now owns 1,732 shares of the company’s stock worth $135,000 after buying an additional 1,016 shares during the last quarter. First Hawaiian Bank bought a new stake in shares of Nu Skin Enterprises in the 3rd quarter worth about $165,000. Ffcm LLC increased its holdings in shares of Nu Skin Enterprises by 181.9% in the 3rd quarter. Ffcm LLC now owns 1,911 shares of the company’s stock worth $177,000 after buying an additional 1,233 shares during the last quarter. Finally, Advisors Asset Management Inc. increased its holdings in shares of Nu Skin Enterprises by 151.9% in the 3rd quarter. Advisors Asset Management Inc. now owns 2,345 shares of the company’s stock worth $193,000 after buying an additional 1,414 shares during the last quarter. Institutional investors and hedge funds own 74.66% of the company’s stock.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Featured Story: Exchange-Traded Funds (ETFs)
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.